Lundbeck’s decade-long damages bid against Sandoz stayed despite High Court win

Intellectual Property 2023-07-04 11:39 pm By Cindy Cameronne | Sydney

Novartis unit Sandoz has won its bid to stay a case by rival Lundbeck, including orders for damages previously calculated at $26.3 million and counting, despite having succeeded at the High Court in a dispute over its patent for blockbuster antidepressant Lexapro.